GB9207339D0 - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
GB9207339D0
GB9207339D0 GB929207339A GB9207339A GB9207339D0 GB 9207339 D0 GB9207339 D0 GB 9207339D0 GB 929207339 A GB929207339 A GB 929207339A GB 9207339 A GB9207339 A GB 9207339A GB 9207339 D0 GB9207339 D0 GB 9207339D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929207339A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Corp
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Corp filed Critical Fisons Corp
Priority to GB929207339A priority Critical patent/GB9207339D0/en
Publication of GB9207339D0 publication Critical patent/GB9207339D0/en
Priority to CZ19942409A priority patent/CZ288519B6/en
Priority to DE69317411T priority patent/DE69317411T2/en
Priority to SG1996005610A priority patent/SG47948A1/en
Priority to DK93907975T priority patent/DK0633879T3/en
Priority to PCT/GB1993/000689 priority patent/WO1993020052A1/en
Priority to PL93305404A priority patent/PL180014B1/en
Priority to NZ251384A priority patent/NZ251384A/en
Priority to EP93907975A priority patent/EP0633879B1/en
Priority to AT93907975T priority patent/ATE163925T1/en
Priority to KR1019940703465A priority patent/KR100259567B1/en
Priority to RU94042465A priority patent/RU2128650C1/en
Priority to AU38976/93A priority patent/AU3897693A/en
Priority to UA94095853A priority patent/UA29437C2/en
Priority to SK1177-94A priority patent/SK281258B6/en
Priority to ES93907975T priority patent/ES2115055T3/en
Priority to CA002133427A priority patent/CA2133427C/en
Priority to JP05517251A priority patent/JP3120810B2/en
Priority to MYPI93000602A priority patent/MY110149A/en
Priority to ZA932415A priority patent/ZA932415B/en
Priority to MX9301935A priority patent/MX9301935A/en
Priority to MA23157A priority patent/MA22866A1/en
Priority to IL105276A priority patent/IL105276A/en
Priority to DZ930038A priority patent/DZ1677A1/en
Priority to CN93104534A priority patent/CN1044367C/en
Priority to TW082103364A priority patent/TW282455B/zh
Priority to FI944546A priority patent/FI105025B/en
Priority to NO943645A priority patent/NO302170B1/en
Priority to HU95P/P00192P priority patent/HU211529A9/en
Priority to AU75456/96A priority patent/AU705419B2/en
Priority to HK98110056A priority patent/HK1009331A1/en
Priority to JP2000159319A priority patent/JP2000319259A/en
Pending legal-status Critical Current

Links

GB929207339A 1992-04-03 1992-04-03 Pharmaceutical compound Pending GB9207339D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
CA002133427A CA2133427C (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
SK1177-94A SK281258B6 (en) 1992-04-03 1993-04-01 (s)-alpha-phenyl-2-pyridineethanamine, pharmaceutical composition containing thereof and use thereof
JP05517251A JP3120810B2 (en) 1992-04-03 1993-04-01 Method for producing a compound for treating a neurodegenerative disease
SG1996005610A SG47948A1 (en) 1992-04-03 1993-04-01 Compounds for the treatment of neurodegenerative disorders
DK93907975T DK0633879T3 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2 (2-pyridinyl) ethylamine for the treatment of neurodegenerative diseases
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
PL93305404A PL180014B1 (en) 1992-04-03 1993-04-01 (s)-alpha-phenyl-2-pyridodiethane amine and pharmaceutic composition containing it
DE69317411T DE69317411T2 (en) 1992-04-03 1993-04-01 ENANTIOMERE 1-PHENYL-2- (2-PYRIDINYL) ETHYLAMINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
EP93907975A EP0633879B1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
AT93907975T ATE163925T1 (en) 1992-04-03 1993-04-01 ENANTIOMERIC 1-PHENYL-2-(2-PYRIDINYL)ETHYLAMINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
KR1019940703465A KR100259567B1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl_ethylamine for the treatment of neurodegenerative disorders
RU94042465A RU2128650C1 (en) 1992-04-03 1993-04-01 (S)-α-PHENYL-2-PYRIDINE ETHANEAMINE AND ITS SALT WITH INORGANIC ACIDS, METHOD OF THEIR SYNTHESIS, DRUG ON THEIR BASIS AND METHOD OF TREATMENT OF PATIENTS WITH CONVULSIONS
AU38976/93A AU3897693A (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
UA94095853A UA29437C2 (en) 1992-04-03 1993-04-01 (S)-a-phenyl -2-pyridinetamine or salt thereof with inorganic acid having anticonvulsant activity, a PROCESS for PREPARATION thereof, medicament on their basis and a method for treatment of convulsions
CZ19942409A CZ288519B6 (en) 1992-04-03 1993-04-01 (S)-alpha-phenyl-2-pyridinethanamine, process of its preparation, pharmaceutical composition in which this enantiomer is comprised, this enantiomer intended for use as medicament and use of this enantiomer for preparing medicaments
ES93907975T ES2115055T3 (en) 1992-04-03 1993-04-01 1-PHENYL-2- (2-PIRIDINYL) ETHYLAMINE ENANTIOMERA FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
NZ251384A NZ251384A (en) 1992-04-03 1993-04-01 (s)-enantiomer of 1-phenyl-2-(2-pyridinyl) ethylamine and medicaments
IL105276A IL105276A (en) 1992-04-03 1993-04-02 (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
MYPI93000602A MY110149A (en) 1992-04-03 1993-04-02 Compounds for the treatment of neurodegenerative disorders
ZA932415A ZA932415B (en) 1992-04-03 1993-04-02 Compounds for the treatment of neurodegenerative disorders
MX9301935A MX9301935A (en) 1992-04-03 1993-04-02 COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE ALTERATIONS.
MA23157A MA22866A1 (en) 1992-04-03 1993-04-02 PROCESS FOR THE PREPARATION OF COMPOUNDS FOR THE TREATMENT OF NEURO-DEGENERATIVE DISORDERS.
CN93104534A CN1044367C (en) 1992-04-03 1993-04-03 Compounds for the treatment of nemodegenerative disorders
DZ930038A DZ1677A1 (en) 1992-04-03 1993-04-03 Process for the preparation of compounds for the treatment of neurodegenerative disorders.
TW082103364A TW282455B (en) 1992-04-03 1993-04-30
FI944546A FI105025B (en) 1992-04-03 1994-09-30 Process for the preparation of (S) -alpha-phenyl-2-pyridinethanamine
NO943645A NO302170B1 (en) 1992-04-03 1994-09-30 Enantiomeric 1-phenyl-2- (2-pyridinyl) ethylamine, pharmaceutical formulation and use thereof
HU95P/P00192P HU211529A9 (en) 1992-04-03 1995-06-13 Compounds for the treatment of neurodegenerative disorders
AU75456/96A AU705419B2 (en) 1992-04-03 1996-12-18 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
HK98110056A HK1009331A1 (en) 1992-04-03 1998-08-21 Enantiomeric 1-phenyl-2-(2-pyridinyl) ethylamine for the treatment of neurodegenerative disorders
JP2000159319A JP2000319259A (en) 1992-04-03 2000-05-30 Compound for treatment of neurological disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
GB9207339D0 true GB9207339D0 (en) 1992-05-13

Family

ID=10713416

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929207339A Pending GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound

Country Status (1)

Country Link
GB (1) GB9207339D0 (en)

Similar Documents

Publication Publication Date Title
PH30215A (en) Pharmaceutical compounds
HU9303261D0 (en) Pharmaceutical compounds
ZA931944B (en) Pharmaceutical compounds
IL101625A0 (en) Pharmaceutical compound
IL101624A0 (en) Pharmaceutical compound
GB9320051D0 (en) Pharmaceutical compounds
GB9226724D0 (en) Pharmaceutical compounds
ZA938546B (en) Pharmaceutical compounds
GB9316923D0 (en) Pharmaceutical compounds
GB9211379D0 (en) Pharmaceutical compounds
GB9205301D0 (en) Pharmaceutical compound
GB9226792D0 (en) Pharmaceutical compound
GB9208189D0 (en) Pharmaceutical compound
GB9207339D0 (en) Pharmaceutical compound
GB9207290D0 (en) Pharmaceutical compound
GB9207166D0 (en) Pharmaceutical compound
GB9207165D0 (en) Pharmaceutical compound
GB9205311D0 (en) Pharmaceutical compound
GB9218090D0 (en) Pharmaceutical compounds
GB9218092D0 (en) Pharmaceutical compounds
GB9226895D0 (en) Pharmaceutical compounds
GB9222650D0 (en) Pharmaceutical compounds
GB9213058D0 (en) Pharmaceutical compounds
GB9209028D0 (en) Pharmaceutical compounds
GB9204302D0 (en) Pharmaceutical compounds